Alpha Score of 32 reflects weak overall profile with poor momentum, weak value, weak quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.
IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company operates three primary divisions: Research & Development, which manages all phases of clinical trials from phase I through IV, including clinical pharmacology, regulatory affairs, protocol design, patient recruitment, data management, and biostatistics for pharmaceutical, device, and diagnostic firms; Technology & Analytics, offering aggregated healthcare data, cloud-based customer relationship management software, analytics consulting, and insights from vast non-identified patient records to pharmaceutical companies, providers, payers, and policymakers; and Contract Sales & Medical, providing sales services and patient engagement to healthcare providers. IQVIA Holdings Inc. leverages IQVIA Connected Intelligence™ to deliver agile, evidence-driven solutions that connect data, technology, and expertise, supporting clinical development, commercialization, and healthcare transformation worldwide. Founded in 2016 and headquartered in Durham, North Carolina, it conducts operations in more than 100 countries, playing a pivotal role in accelerating innovations for better patient outcomes in the healthcare ecosystem.
Earnings calendar coming soon. Subscribe to get notified when IQV reports next.
Get earnings alerts →